Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Accounts receivable, allowance	$ (21,647)	$ (15,951)
Deferred financing costs	$ (10,578)	$ (13,044)
Common shares, par value (in USD per share)	$ 0.01	$ 0.01
Common shares, shares authorized (in shares)	500,000,000	500,000,000
Common shares, shares issued (in shares)	283,699,120	269,814,956
Common Stock
Common shares, shares outstanding (in shares)	283,699,120	269,814,956